Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
06/15/2011 | EP2332533A1 Cannabinoid-containing plant extracts as neuroprotective agents |
06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
06/15/2011 | EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
06/15/2011 | EP2332424A1 Method for producing lipid |
06/15/2011 | EP2331578A1 Novel compositons and methods for treating ige-mediated disorders |
06/15/2011 | EP2331541A1 Indolizine inhibitors of leukotriene production |
06/15/2011 | EP2331526A2 Pyrimidine derivatives as kinase inhibitors |
06/15/2011 | EP1784399B1 Pyrimidine derivatives |
06/15/2011 | EP1389618B1 Pyrazolo 1,5-a pyridines and medicines containing the same |
06/15/2011 | EP1131080B2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
06/15/2011 | EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof |
06/15/2011 | EP0939804B2 NEUTROKINE alpha |
06/15/2011 | CN201861992U Multiple coating mirco-capsulation lactic acid bacteria (MCM-LAB) structure |
06/15/2011 | CN1849135B Methods for treating interleukin-6-related diseases |
06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
06/15/2011 | CN102099471A Aptamer against il-17 and use thereof |
06/15/2011 | CN102099374A Methods and compositions for modulating angiogenesis and pericyte composition |
06/15/2011 | CN102099342A Aminotetrahydroindazoloacetic acids |
06/15/2011 | CN102093598A Composite edible fungi polysaccharides and preparation method thereof |
06/15/2011 | CN102093460A Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
06/15/2011 | CN102093452A Hydrogenation type ginsenoside aglycons as well as preparation method and application of hydrogenation type ginsenoside aglycons |
06/15/2011 | CN102093421A Phosphorus substituent group-containing quinoline compound and preparation method of quinoline compound as well as pharmaceutical composition containing quinoline compound and application of pharmaceutical composition |
06/15/2011 | CN102093380A Cyclic icaritin aglycon as well as preparation method and application of cyclic icaritin aglycon |
06/15/2011 | CN102093373A Compounds formed by structural modifiecation of sinomenine and preparation method thereof |
06/15/2011 | CN102093364A 2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor |
06/15/2011 | CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
06/15/2011 | CN102093250A Glutamine dipeptide compound and novel method thereof |
06/15/2011 | CN102093187A Polyketone compounds and application thereof |
06/15/2011 | CN102091317A Qi-tonifying desensitizer and use thereof |
06/15/2011 | CN102091277A Negative ion far-infrared immune synergist with nano-selenium and germanium and traditional Chinese medicine elements |
06/15/2011 | CN102091268A Medicament for treating allergic rhinitis and preparation method thereof |
06/15/2011 | CN102091220A Traditional Chinese medicine for treating endogenous heat disease |
06/15/2011 | CN102091216A Process for processing aloe juice |
06/15/2011 | CN102091152A Traditional Chinese medicinal composition with stomach-invigorating and digestion-promoting function and preparation method thereof |
06/15/2011 | CN102091148A Coating method for miraculous pill of ledebouriella |
06/15/2011 | CN102091133A Nano selenium-germanium snake anion far infrared body-building life-prolonging health-care drink |
06/15/2011 | CN102091132A Method for detecting esculin, aesculetin, fraxin and fraxetin in cortex fraxini or extract thereof |
06/15/2011 | CN102091100A Method for improving main medicinal ingredients through solid fermentation of Indian buead and cordyceps militaris |
06/15/2011 | CN102091089A Application of active burdock oligosaccharide to aquaculture |
06/15/2011 | CN102091014A Strengthened nanometer element traditional Chinese medicine anion far infrared functional perfume |
06/15/2011 | CN102091006A Tea extract facial cleanser and preparation method thereof |
06/15/2011 | CN102090636A PUFA supplements |
06/15/2011 | CN102090629A Dual-purpose food--medicament product capable of delaying aging and preparation method thereof |
06/15/2011 | CN102090622A Sparassia crispa(Wulf.)Fr. solution preparation method |
06/15/2011 | CN102090560A Synergism of GOS and polyfructose |
06/15/2011 | CN102090558A Composition containing probiotics, DHA (docosahexaenoic acid) and lactoferrin and applications thereof |
06/15/2011 | CN102090532A Immunopotentiator for large yellow croaker juvenile |
06/15/2011 | CN101732362B Application of wild truffle in preparing medicine with anticancer and immunological functions |
06/15/2011 | CN101716158B Method for preparing matrine slow-release tablet by applying attapulgite |
06/15/2011 | CN101618050B Compound fungus polysaccharide with function of enhancing immunity and application thereof |
06/15/2011 | CN101584766B Compound schizonepeta Chinese medicinal soup used for treating urticaria |
06/15/2011 | CN101530443B Asarum volatile oil prepared by system solvent method and use thereof |
06/15/2011 | CN101507734B Deer-bone serial processing method |
06/15/2011 | CN101407554B Sodium carboxymethylstarch and preparation thereof |
06/15/2011 | CN101322810B Chinese traditional medicine composition for treating diabetes respiratory tract infection |
06/15/2011 | CN101301316B Compound formulation containing lactobacillus leavening and preparation and use thereof |
06/15/2011 | CN101229320B Glutathione ammoniacum compounds and processing method thereof |
06/15/2011 | CN101194919B Hippophae rhamnoides seed oil fatty milk injection and technique of preparing the same |
06/15/2011 | CN101130515B Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same |
06/15/2011 | CN101111495B Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
06/15/2011 | CN101056855B Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
06/15/2011 | CN101044120B Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
06/15/2011 | CA2725435A1 Vaccines for inclusion body hepatitis |
06/14/2011 | US7960570 Small molecule inhibitors of rotamase enzyme activity |
06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
06/14/2011 | US7960407 Crystal forms of an imidazole derivative |
06/14/2011 | US7960397 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions |
06/14/2011 | US7960395 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors |
06/14/2011 | US7960369 Receptor function regulator |
06/14/2011 | US7960366 Substituted tetracycline compounds as synergistic antifungal agents |
06/14/2011 | US7960351 Method for producing pectin hydrolysis products |
06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
06/14/2011 | CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
06/14/2011 | CA2382331C Vaccine against intra-cellular pathogens |
06/14/2011 | CA2327389C Dna vaccine for horses containing as at least one adjuvant, polymers of acrylic or methacrylic acid, or copolymers of maleic anhydride and ethylene |
06/14/2011 | CA2301327C Use of herpes vectors for tumor therapy |
06/14/2011 | CA2200540C Use of l-carnitine or derivatives thereof and antioxidants for the prevention and treatment of diseases elicited by oxidative stress to the nervous and cardiovascular system |
06/09/2011 | WO2011068953A2 Atoxic recombinant holotoxins of clostridium difficile as immunogens |
06/09/2011 | WO2011068853A2 TREATMENT OF IgE-MEDIATED DISEASE |
06/09/2011 | WO2011068233A1 Imidazoquinolines which act via toll - like receptors (tlr) |
06/09/2011 | WO2011068226A1 Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages |
06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
06/09/2011 | WO2011067560A1 Combination of droloxifene and clopidogrel |
06/09/2011 | WO2011067366A1 Indazole derivatives as pi 3 - kinase inhibitors |
06/09/2011 | WO2011050054A3 Coumarin compounds as receptor modulators with therapeutic utility |
06/09/2011 | WO2011041886A8 Vaccines comprising heat-sensitive transgenes |
06/09/2011 | US20110136922 Activation induced deaminase (aid) |
06/09/2011 | US20110136911 Treatment of sepsis and inhibition of mif by d-t4 |
06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
06/09/2011 | US20110136860 Compounds |
06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
06/09/2011 | US20110136834 Inhibitors of e1 activating enzymes |
06/09/2011 | US20110136816 Compounds that modulate intracellular calcium |
06/09/2011 | US20110136796 IDO Inhibitors |
06/09/2011 | US20110136790 Tricyclic Heterocyclic Derivatives and Methods of Use |